Clinical Trial

ETASCAN Project: ETAS Project 2

Study acronym: ETASCAN
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to investigate the chronic effects of ETAS® on cognitive, affective and neural outcomes in healthy adults aged 60-80 years with mild to moderate subjective cognitive complaints.
Trial Details
NCT Number NCT07550140
Lead Sponsor University of Reading
Collaborators: Amino Up Chemicals Co., Ltd.
Conditions Cognition, Affect (Mental Function), Sleep, MRI, fMRI, Magnetic Resonance Spectroscopy
Enrollment 60 participants
Start Date 2026-05-05
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-24